Table 1 Baseline demographic characteristics and clinical data of TN patients given single or repeated dose BTX-Aa
Single dose | Repeated dose | P | ||
|---|---|---|---|---|
Subjects, n | 44 | 37 | ||
Age, yb | 60.73 ± 10.88 | 57.14 ± 10.39 | 0.056 | |
Disease course, mo b | 73.50 ± 63.63 | 50.46 ± 43.95 | 0.059 | |
Gender | Male | 19 (43.2%) | 16 (43.2%) | 1 |
Female | 25 (56.8%) | 21 (56.8%) | ||
Side | Left | 17 (38.6%) | 14 (37.8%) | 1 |
Right | 27 (61.4%) | 23 (62.2%) | ||
Nerve branch | 1 | 5 (11.4%) | 3 (8.1%) | 0.324 |
2 | 10 (22.7%) | 11 (29.7%) | ||
3 | 11 (25.0%) | 8 (21.6%) | ||
1, 2 | 8 (18.2%) | 3 (8.1%) | ||
1, 3 | 2 (4.5%) | 0 (0.0%) | ||
2, 3 | 8 (18.2%) | 10 (27.0%) | ||
1, 2, 3 | 0 (0.0%) | 2 (5.4%) | ||
Toothache | Yes | 11 (25.0%) | 15 (40.5%) | 0.158 |
No | 33 (75.0%) | 22 (59.5%) |